Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells
Details for Australian Patent Application No. 2008310894 (hide)
International Classifications
Event Publications
6 May 2010 PCT application entered the National Phase
PCT publication WO2009/048953 Priority application(s): WO2009/048953
22 July 2010 Alteration of Name
The name of the applicant has been altered to The Trustees of the University of Pennsylvania; GlaxoSmithKline LLC
26 July 2012 Application Accepted
Published as AU-B-2008310894
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008310895-Magnetic anastomosis device having improved delivery
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser